GATA3 Immunohistochemical Expression in Salivary Gland Neoplasms

Lauren E. Schwartz, Shahnaz Begum, William H. Westra, Justin A. Bishop

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

GATA3 is a zinc finger transcription factor that regulates the normal development of many tissues and cell types. Recent studies have shown that immunohistochemical nuclear staining for GATA3 among tumors is highly restricted to carcinomas of breast and urothelial origin; however salivary gland tumors have not been tested. Given that breast and salivary gland tissues are very similar with respect to embryologic development and structure, we performed GATA3 staining on a spectrum of salivary gland neoplasms. GATA3 immunohistochemistry was performed on a diverse collection of 180 benign and malignant salivary gland neoplasms including 10 acinic cell carcinomas, 2 adenocarcinomas not otherwise specified, 41 adenoid cystic carcinomas, 2 epithelial-myoepithelial carcinomas, 1 low grade cribriform cystadenocarcinoma, 15 mammary analogue secretory carcinomas, 7 metastatic squamous cell carcinomas, 27 mucoepidermoid carcinomas, 2 oncocytic carcinomas, 5 oncocytomas, 34 pleomorphic adenomas, 4 polymorphous low grade adenocarcinomas, 25 salivary duct carcinomas, and 5 Warthin tumors. Staining for GATA3 was observed in 92/180 (51 %) of salivary gland tumors. GATA3 staining was observed in most of the tumor types, but diffuse immunolabeling was consistently seen in salivary duct carcinoma (25 of 25) and mammary analogue secretory carcinoma (15 of 15)-the two tumor types that most closely resemble breast neoplasia. Background benign salivary gland tissue was also usually weakly positive in both acini and ducts. GATA3 immunostaining is not restricted to tumors of breast and urothelial origin. Rather, it is expressed across many different types of salivary gland neoplasms. As a result, salivary gland origin should be considered in the differential diagnosis of a GATA3-positive carcinoma, particularly in the head and neck. Although GATA3 immunohistochemistry is not helpful in resolving the differential diagnosis between a primary salivary gland neoplasm and metastatic breast cancer, it may have some utility in subtyping salivary gland tumors, particularly salivary duct carcinoma and mammary analogue secretory carcinoma.

Original languageEnglish (US)
Pages (from-to)311-315
Number of pages5
JournalHead and Neck Pathology
Volume7
Issue number4
DOIs
StatePublished - Dec 1 2013

Fingerprint

Salivary Gland Neoplasms
Salivary Ducts
Carcinoma
Glandular and Epithelial Neoplasms
Salivary Glands
Staining and Labeling
Breast Neoplasms
Neoplasms
Adenocarcinoma
Breast
Differential Diagnosis
Immunohistochemistry
Cystadenocarcinoma
Adenolymphoma
Acinar Cell Carcinoma
Mucoepidermoid Carcinoma
Oxyphilic Adenoma
Pleomorphic Adenoma
Adenoid Cystic Carcinoma
Zinc Fingers

Keywords

  • GATA3
  • Immunohistochemistry
  • Mammary analogue secretory carcinoma
  • Salivary duct carcinoma
  • Salivary glands

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Oncology
  • Otorhinolaryngology

Cite this

GATA3 Immunohistochemical Expression in Salivary Gland Neoplasms. / Schwartz, Lauren E.; Begum, Shahnaz; Westra, William H.; Bishop, Justin A.

In: Head and Neck Pathology, Vol. 7, No. 4, 01.12.2013, p. 311-315.

Research output: Contribution to journalArticle

Schwartz, Lauren E. ; Begum, Shahnaz ; Westra, William H. ; Bishop, Justin A. / GATA3 Immunohistochemical Expression in Salivary Gland Neoplasms. In: Head and Neck Pathology. 2013 ; Vol. 7, No. 4. pp. 311-315.
@article{bd0a6fb72cee4bf3a2b3aadfbe7b38ba,
title = "GATA3 Immunohistochemical Expression in Salivary Gland Neoplasms",
abstract = "GATA3 is a zinc finger transcription factor that regulates the normal development of many tissues and cell types. Recent studies have shown that immunohistochemical nuclear staining for GATA3 among tumors is highly restricted to carcinomas of breast and urothelial origin; however salivary gland tumors have not been tested. Given that breast and salivary gland tissues are very similar with respect to embryologic development and structure, we performed GATA3 staining on a spectrum of salivary gland neoplasms. GATA3 immunohistochemistry was performed on a diverse collection of 180 benign and malignant salivary gland neoplasms including 10 acinic cell carcinomas, 2 adenocarcinomas not otherwise specified, 41 adenoid cystic carcinomas, 2 epithelial-myoepithelial carcinomas, 1 low grade cribriform cystadenocarcinoma, 15 mammary analogue secretory carcinomas, 7 metastatic squamous cell carcinomas, 27 mucoepidermoid carcinomas, 2 oncocytic carcinomas, 5 oncocytomas, 34 pleomorphic adenomas, 4 polymorphous low grade adenocarcinomas, 25 salivary duct carcinomas, and 5 Warthin tumors. Staining for GATA3 was observed in 92/180 (51 {\%}) of salivary gland tumors. GATA3 staining was observed in most of the tumor types, but diffuse immunolabeling was consistently seen in salivary duct carcinoma (25 of 25) and mammary analogue secretory carcinoma (15 of 15)-the two tumor types that most closely resemble breast neoplasia. Background benign salivary gland tissue was also usually weakly positive in both acini and ducts. GATA3 immunostaining is not restricted to tumors of breast and urothelial origin. Rather, it is expressed across many different types of salivary gland neoplasms. As a result, salivary gland origin should be considered in the differential diagnosis of a GATA3-positive carcinoma, particularly in the head and neck. Although GATA3 immunohistochemistry is not helpful in resolving the differential diagnosis between a primary salivary gland neoplasm and metastatic breast cancer, it may have some utility in subtyping salivary gland tumors, particularly salivary duct carcinoma and mammary analogue secretory carcinoma.",
keywords = "GATA3, Immunohistochemistry, Mammary analogue secretory carcinoma, Salivary duct carcinoma, Salivary glands",
author = "Schwartz, {Lauren E.} and Shahnaz Begum and Westra, {William H.} and Bishop, {Justin A.}",
year = "2013",
month = "12",
day = "1",
doi = "10.1007/s12105-013-0442-3",
language = "English (US)",
volume = "7",
pages = "311--315",
journal = "Head and Neck Pathology",
issn = "1936-055X",
publisher = "Humana Press",
number = "4",

}

TY - JOUR

T1 - GATA3 Immunohistochemical Expression in Salivary Gland Neoplasms

AU - Schwartz, Lauren E.

AU - Begum, Shahnaz

AU - Westra, William H.

AU - Bishop, Justin A.

PY - 2013/12/1

Y1 - 2013/12/1

N2 - GATA3 is a zinc finger transcription factor that regulates the normal development of many tissues and cell types. Recent studies have shown that immunohistochemical nuclear staining for GATA3 among tumors is highly restricted to carcinomas of breast and urothelial origin; however salivary gland tumors have not been tested. Given that breast and salivary gland tissues are very similar with respect to embryologic development and structure, we performed GATA3 staining on a spectrum of salivary gland neoplasms. GATA3 immunohistochemistry was performed on a diverse collection of 180 benign and malignant salivary gland neoplasms including 10 acinic cell carcinomas, 2 adenocarcinomas not otherwise specified, 41 adenoid cystic carcinomas, 2 epithelial-myoepithelial carcinomas, 1 low grade cribriform cystadenocarcinoma, 15 mammary analogue secretory carcinomas, 7 metastatic squamous cell carcinomas, 27 mucoepidermoid carcinomas, 2 oncocytic carcinomas, 5 oncocytomas, 34 pleomorphic adenomas, 4 polymorphous low grade adenocarcinomas, 25 salivary duct carcinomas, and 5 Warthin tumors. Staining for GATA3 was observed in 92/180 (51 %) of salivary gland tumors. GATA3 staining was observed in most of the tumor types, but diffuse immunolabeling was consistently seen in salivary duct carcinoma (25 of 25) and mammary analogue secretory carcinoma (15 of 15)-the two tumor types that most closely resemble breast neoplasia. Background benign salivary gland tissue was also usually weakly positive in both acini and ducts. GATA3 immunostaining is not restricted to tumors of breast and urothelial origin. Rather, it is expressed across many different types of salivary gland neoplasms. As a result, salivary gland origin should be considered in the differential diagnosis of a GATA3-positive carcinoma, particularly in the head and neck. Although GATA3 immunohistochemistry is not helpful in resolving the differential diagnosis between a primary salivary gland neoplasm and metastatic breast cancer, it may have some utility in subtyping salivary gland tumors, particularly salivary duct carcinoma and mammary analogue secretory carcinoma.

AB - GATA3 is a zinc finger transcription factor that regulates the normal development of many tissues and cell types. Recent studies have shown that immunohistochemical nuclear staining for GATA3 among tumors is highly restricted to carcinomas of breast and urothelial origin; however salivary gland tumors have not been tested. Given that breast and salivary gland tissues are very similar with respect to embryologic development and structure, we performed GATA3 staining on a spectrum of salivary gland neoplasms. GATA3 immunohistochemistry was performed on a diverse collection of 180 benign and malignant salivary gland neoplasms including 10 acinic cell carcinomas, 2 adenocarcinomas not otherwise specified, 41 adenoid cystic carcinomas, 2 epithelial-myoepithelial carcinomas, 1 low grade cribriform cystadenocarcinoma, 15 mammary analogue secretory carcinomas, 7 metastatic squamous cell carcinomas, 27 mucoepidermoid carcinomas, 2 oncocytic carcinomas, 5 oncocytomas, 34 pleomorphic adenomas, 4 polymorphous low grade adenocarcinomas, 25 salivary duct carcinomas, and 5 Warthin tumors. Staining for GATA3 was observed in 92/180 (51 %) of salivary gland tumors. GATA3 staining was observed in most of the tumor types, but diffuse immunolabeling was consistently seen in salivary duct carcinoma (25 of 25) and mammary analogue secretory carcinoma (15 of 15)-the two tumor types that most closely resemble breast neoplasia. Background benign salivary gland tissue was also usually weakly positive in both acini and ducts. GATA3 immunostaining is not restricted to tumors of breast and urothelial origin. Rather, it is expressed across many different types of salivary gland neoplasms. As a result, salivary gland origin should be considered in the differential diagnosis of a GATA3-positive carcinoma, particularly in the head and neck. Although GATA3 immunohistochemistry is not helpful in resolving the differential diagnosis between a primary salivary gland neoplasm and metastatic breast cancer, it may have some utility in subtyping salivary gland tumors, particularly salivary duct carcinoma and mammary analogue secretory carcinoma.

KW - GATA3

KW - Immunohistochemistry

KW - Mammary analogue secretory carcinoma

KW - Salivary duct carcinoma

KW - Salivary glands

UR - http://www.scopus.com/inward/record.url?scp=84886752876&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886752876&partnerID=8YFLogxK

U2 - 10.1007/s12105-013-0442-3

DO - 10.1007/s12105-013-0442-3

M3 - Article

VL - 7

SP - 311

EP - 315

JO - Head and Neck Pathology

JF - Head and Neck Pathology

SN - 1936-055X

IS - 4

ER -